Schedule 13G ownership disclosure

Sagimet Biosciences Inc

Series A Common Stock, $0.0001 par value per share · CUSIP: 786700104

Event date: 2025-12-18

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • KPCB Pandemic and Bio Defense Fund, LLC

    Shares: 0.00 · Class: 0.0%

  • KPCB PBD Associates, LLC

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-122583
Form type
SCHEDULE 13G/A
Filer
KPCB PANDEMIC & BIO DEFENSE FUND LLC
CIK
CIK 1356809
Filed
Dec 18, 2025
Reporting period
Dec 18, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub